Login
Super Investors PACIFIC VIEW ASSET MANAGEMENT, LLC
PV

PACIFIC VIEW ASSET MANAGEMENT, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$20.8M
Positions
5
Quarter ended
September 30, 2019
Filed
November 14, 2019

Reported portfolio value by quarter (8 quarters reported)

$151M $20.8M
Q4 17 Q2 18 Q4 18 Q2 19 Q3 19

$151M in Q4 2017 → $20.8M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2019. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
UT Universal Technical Inst Inc 59.9% Unchanged 2,292,487 $12.5M
Gulf Island Fabrication Inc 18.6% Unchanged 723,407 $3.87M
GS Gse Sys Inc 13.9% Unchanged 1,658,819 $2.9M
HI Hill International Inc 3.9% Trimmed 44% 273,270 $817K
KB Kindred Biosciences Inc 3.7% Unchanged 112,887 $773K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.

Q3 2019

quarter ended September 30, 2019 · filed November 14, 2019

Company Action Shares changed Value of change % of portfolio
Ameris Bancorp Exited −125,341 −$4.91M —
GC Granite Constr Inc Exited −97,970 −$4.72M —
AT Aimmune Therapeutics Inc Exited −222,117 −$4.62M —
PF Pinnacle Finl Partners Inc Exited −80,135 −$4.61M —
PH Pra Health Sciences Inc Exited −46,465 −$4.61M —
IP Intercept Pharmaceuticals In Exited −51,832 −$4.12M —
IB Investors Bancorp Inc New Exited −323,246 −$3.6M —
SH Syneos Health Inc Exited −69,977 −$3.57M —
AP Aerie Pharmaceuticals Inc Exited −120,230 −$3.55M —
Home Bancshares Inc Exited −163,839 −$3.16M —

Showing the 10 largest of 46 changes.

Q2 2019

quarter ended June 30, 2019 · filed August 14, 2019

Company Action Shares changed Value of change % of portfolio
Sage Therapeutics Inc Trimmed −28,023 −$5.13M 1.1%
PH Pra Health Sciences Inc Added +38,621 +$3.83M 5.0%
SH Syneos Health Inc Added +52,498 +$2.68M 3.9%
GC Granite Constr Inc Added +54,246 +$2.61M 5.1%
AI Abm Inds Inc Trimmed −51,263 −$2.05M 0.9%
HP Horizon Pharma PLC Exited −76,448 −$2.02M —
SM Summit Matls Inc Trimmed −84,954 −$1.64M 0.5%
8N 8x8 Inc New Trimmed −61,401 −$1.48M 0.8%
HT Horizon Therapeutics Pub Ltd New +58,902 +$1.42M 1.5%
RN Rexnord Corp New New +44,886 +$1.36M 1.5%

Showing the 10 largest of 51 changes.

Q1 2019

quarter ended March 31, 2019 · filed May 15, 2019

Company Action Shares changed Value of change % of portfolio
IP Intercept Pharmaceuticals In New +50,601 +$5.66M 5.9%
Sage Therapeutics Inc Added +29,896 +$4.76M 5.5%
LO Loxo Oncology Inc Exited −21,775 −$3.05M —
P Proofpoint Inc Exited −35,904 −$3.01M —
I Immunomedics Inc Trimmed −144,409 −$2.78M 1.3%
AB Array Biopharma Inc Trimmed −111,908 −$2.73M 0.9%
GC Granite Constr Inc Trimmed −42,173 −$1.82M 2.0%
A Asgn Inc Added +26,609 +$1.69M 2.0%
AI Abm Inds Inc Added +41,766 +$1.52M 2.7%
Ameris Bancorp Added +43,969 +$1.51M 4.4%

Showing the 10 largest of 56 changes.

Q4 2018

quarter ended December 31, 2018 · filed February 14, 2019

Company Action Shares changed Value of change % of portfolio
GX Global X Fds Exited −314,000 −$4.18M —
LH Limbach Hldgs Inc Exited −369,604 −$4.17M —
AB Array Biopharma Inc Trimmed −208,205 −$2.96M 2.5%
P Proofpoint Inc Added +33,529 +$2.81M 3.5%
SH Syneos Health Inc Trimmed −64,110 −$2.52M 1.1%
HI Hill International Inc New +760,000 +$2.34M 2.8%
LO Loxo Oncology Inc Added +16,321 +$2.29M 3.6%
Madrigal Pharmaceuticals Inc Added +16,380 +$1.85M 3.3%
Ameris Bancorp Added +44,149 +$1.4M 2.9%
Hawaiian Holdings Inc Exited −30,040 −$1.21M —

Showing the 10 largest of 82 changes.

Q3 2018

quarter ended September 30, 2018 · filed November 14, 2018

Company Action Shares changed Value of change % of portfolio
Sage Therapeutics Inc Trimmed −26,766 −$3.78M 0.9%
PH Pra Health Sciences Inc Trimmed −28,592 −$3.15M 0.7%
LH Limbach Hldgs Inc Added +278,744 +$3.14M 3.3%
KB Kindred Biosciences Inc Trimmed −202,135 −$2.82M 3.8%
SH Syneos Health Inc Added +51,248 +$2.64M 3.6%
I Immunomedics Inc Added +103,951 +$2.17M 2.5%
AB Array Biopharma Inc Added +129,646 +$1.97M 4.3%
VV Vaneck Vectors ETF Tr Exited −56,300 −$1.84M —
AD Advanced Disp Svcs Inc Del Trimmed −63,503 −$1.71M 0.8%
Madrigal Pharmaceuticals Inc Added +7,403 +$1.59M 1.5%

Showing the 10 largest of 97 changes.

Q2 2018

quarter ended June 30, 2018 · filed August 14, 2018

Company Action Shares changed Value of change % of portfolio
VV Vaneck Vectors ETF Tr Exited −452,000 −$14.5M —
IS Ishares Silver Trust Exited −794,400 −$12.2M —
GC Granite Constr Inc Added +79,829 +$4.44M 3.9%
AB Array Biopharma Inc New +225,511 +$3.78M 3.0%
AP Aerie Pharmaceuticals Inc Added +44,069 +$2.98M 3.7%
Transocean Ltd Exited −285,500 −$2.83M —
Monro Inc Exited −45,270 −$2.43M —
PF Pinnacle Finl Partners Inc Added +37,896 +$2.33M 3.9%
AT Aimmune Therapeutics Inc Added +85,644 +$2.3M 4.1%
Sage Therapeutics Inc Added +13,697 +$2.14M 4.4%

Showing the 10 largest of 125 changes.

Q1 2018

quarter ended March 31, 2018 · filed May 15, 2018

Company Action Shares changed Value of change % of portfolio
VV Vaneck Vectors ETF Tr New +452,000 +$14.5M 10.9%
IS Ishares Silver Trust New +794,400 +$12.2M 9.2%
KT Key Technology Inc Exited −608,125 −$11.2M —
AP Aerie Pharmaceuticals Inc Trimmed −73,753 −$4M 1.0%
P Proofpoint Inc Trimmed −34,446 −$3.91M 0.2%
AT Aimmune Therapeutics Inc New +108,984 +$3.47M 2.6%
Ameris Bancorp Trimmed −58,173 −$3.07M 0.4%
Transocean Ltd New +285,500 +$2.83M 2.1%
IB Investors Bancorp Inc New Trimmed −202,852 −$2.77M 1.9%
B& B & G Foods Inc New Exited −69,514 −$2.45M —

Showing the 10 largest of 133 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support